GB0304648D0 - New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl)thieno(2,3-D)pyrimidine - Google Patents

New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl)thieno(2,3-D)pyrimidine

Info

Publication number
GB0304648D0
GB0304648D0 GB0304648A GB0304648A GB0304648D0 GB 0304648 D0 GB0304648 D0 GB 0304648D0 GB 0304648 A GB0304648 A GB 0304648A GB 0304648 A GB0304648 A GB 0304648A GB 0304648 D0 GB0304648 D0 GB 0304648D0
Authority
GB
United Kingdom
Prior art keywords
piperzinyl
thieno
fluorophenyl
pyrimidine
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0304648A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arachnova Therapeutics Ltd
Original Assignee
Arachnova Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arachnova Therapeutics Ltd filed Critical Arachnova Therapeutics Ltd
Priority to GB0304648A priority Critical patent/GB0304648D0/en
Publication of GB0304648D0 publication Critical patent/GB0304648D0/en
Priority to KR1020057000141A priority patent/KR101061684B1/en
Priority to CNA038162903A priority patent/CN1668307A/en
Priority to AT03762820T priority patent/ATE424826T1/en
Priority to BR0312511-4A priority patent/BR0312511A/en
Priority to AU2003255712A priority patent/AU2003255712B2/en
Priority to JP2004519012A priority patent/JP2005533829A/en
Priority to US10/519,594 priority patent/US7470690B2/en
Priority to DE60326585T priority patent/DE60326585D1/en
Priority to CA2491836A priority patent/CA2491836C/en
Priority to EP03762820A priority patent/EP1519728B1/en
Priority to PCT/GB2003/002974 priority patent/WO2004004734A1/en
Ceased legal-status Critical Current

Links

GB0304648A 2002-07-10 2003-02-28 New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl)thieno(2,3-D)pyrimidine Ceased GB0304648D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB0304648A GB0304648D0 (en) 2003-02-28 2003-02-28 New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl)thieno(2,3-D)pyrimidine
PCT/GB2003/002974 WO2004004734A1 (en) 2002-07-10 2003-07-09 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder
BR0312511-4A BR0312511A (en) 2002-07-10 2003-07-09 4- (2-fluorophenyl) -6-methyl-2- (1-piperazinyl) thieno [2,3-d] pyrimidine in the treatment of functional bowel disorder
CNA038162903A CN1668307A (en) 2002-07-10 2003-07-09 New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidine
AT03762820T ATE424826T1 (en) 2002-07-10 2003-07-09 4-(2-FLUOROPHENYL)-6-METHYL-2(1-PIPERAZINYL)THIENO(2,3-D) PYRIMIDINE IN THE TREATMENT OF FUNCTIONAL INTESTINAL DISORDERS
KR1020057000141A KR101061684B1 (en) 2002-07-10 2003-07-09 4- (2-fluorophenyl) -6-methyl-2- (1-piperazinyl) thieno [2,3-di] pyrimidine in the treatment of functional bowel disorders
AU2003255712A AU2003255712B2 (en) 2002-07-10 2003-07-09 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-D) pyrimidine in the treatment of functional bowel disorder
JP2004519012A JP2005533829A (en) 2002-07-10 2003-07-09 4- (2-Fluorophenyl) -6-methyl-2- (1-piperazinyl) thieno [2,3-D] pyrimidine in the treatment of functional bowel disease
US10/519,594 US7470690B2 (en) 2002-07-10 2003-07-09 4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder
DE60326585T DE60326585D1 (en) 2002-07-10 2003-07-09 4- (2-fluorophenyl) -6-methyl-2 (1-piperazinyl) thieno (2,3-D) pyrimidine in the treatment of functional disorders
CA2491836A CA2491836C (en) 2002-07-10 2003-07-09 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder
EP03762820A EP1519728B1 (en) 2002-07-10 2003-07-09 4-(2-fluorophenyl)-6-methyl-2(1-piperazinyl)thieno(2,3-d) pyrimidine in the treatment of functional bowel disorder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0304648A GB0304648D0 (en) 2003-02-28 2003-02-28 New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl)thieno(2,3-D)pyrimidine

Publications (1)

Publication Number Publication Date
GB0304648D0 true GB0304648D0 (en) 2003-04-02

Family

ID=9953882

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0304648A Ceased GB0304648D0 (en) 2002-07-10 2003-02-28 New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl)thieno(2,3-D)pyrimidine

Country Status (1)

Country Link
GB (1) GB0304648D0 (en)

Similar Documents

Publication Publication Date Title
IL187528A0 (en) Use of pyrimidine compounds in the manufacture of medicaments
EP1401840A4 (en) Novel 4-amino-5,6-substituted thiopheno 2,3-d|pyrimidines
ATE387446T1 (en) PYRIDO(2,3-D)PYRIMIDINE-2,4-DIAMINE AS PDE-2 INHIBITORS
NO20023527D0 (en) Pyrido (2,3-d) pyrimidine-2,7-diamine kinase inhibitors
IL168102A0 (en) Chk-, pdk-and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
HK1087108A1 (en) 5,7-diaminopyrazolo[4,3-d] pyrimidines useful in the treatment of hypertension
ZA200606009B (en) Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof
HRP20020798A2 (en) 5-ALKYLPYRIDO[2,3-d]PYRIMIDINES TYROZINE KINASE INHIBITORS
ZA200501381B (en) New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
HK1070071A1 (en) New pyrimidine compounds
PL367130A1 (en) Cdk inhibiting pyrimidines, production thereof and their use as medicaments
EP1670466A4 (en) Preparation of 1, 6, 7- trisubstituted azabenzimidazoles as kinase inhibitors
EP1432713A4 (en) Fused pyrimidine dhfr inhibitors as antibacterials
GB0305150D0 (en) Use of therapeutic compounds
EP1498125A4 (en) Use of compounds having ccr antagonism
EP1492510A4 (en) Low dose liquid entecavir formulations and use
EP1399175A4 (en) Therapeutic use of rank antagonists
AU2003299100A1 (en) Pyrimidine compounds as therapeutic agents
AU2003219661A8 (en) Thieno (3, 2-b) pyridones as antiviral compounds
GB0202265D0 (en) New therapeutic use
PL363077A1 (en) Use of pyrazolo[4,3-d]pyrimidines
GB0112494D0 (en) New therapeutic use
DE60326585D1 (en) 4- (2-fluorophenyl) -6-methyl-2 (1-piperazinyl) thieno (2,3-D) pyrimidine in the treatment of functional disorders
GB0304648D0 (en) New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperzinyl)thieno(2,3-D)pyrimidine
GB0216027D0 (en) New therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)